sellas life sciences group stock

The shares were acquired at an average cost of GBX 220 276 per share with a total value of 425920. On Thursday April 28th David Kemp purchased 1936 shares of John Wood Group stock.

Pin On Information Is Wealth

Find the latest SELLAS Life Sciences Group Inc.

. They currently have. SELLAS Life Sciences Group Inc NASDAQ Updated Jun 30 2022 400 AM. Share your opinion and gain insight from other stock traders and investors.

Get the latest news and analysis in the stock market today including national and world stock market news business news financial news and more. SELLAS Life Sciences Group Inc. SLS 226 005 226.

SELLAS Life Sciences Group NASDAQSLS Get Rating had its target price trimmed by Cantor Fitzgerald from 1000 to 600 in a report published on Tuesday The Fly reports. Is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. SELLAS Life Sciences Group Inc SLS announced updated data from a Phase 1 clinical trial of galinpepimut-S GPS combined with Bristol-Myers Squibb Cos BMY nivolumab Opdivo in with malignant.

SLS stock discussion in Yahoo Finances forum. The Companys lead product candidate galinpepimut-S GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that.

Dana Point History Dana Point Mission San Juan Capistrano California Coastline

Dana Point History Dana Point Ca History Dana